NASDAQ:STAB

Statera BioPharma Stock Forecast, Price & News

$3.22

+0.38 (+13.38 %)

(As of 10/15/2021 04:00 PM ET)

Add

Compare

Today's Range

$2.85

▼

$3.85

50-Day Range N/A

52-Week Range

$2.11

▼

$10.97

Volume2.51 million shs

Average Volume265,103 shs

Market Capitalization$82.59 million

P/E RatioN/A

Dividend YieldN/A

Beta0.61

30 days | 90 days | 365 days | Advanced Chart

Receive STAB News and Ratings via Email

Sign-up to receive the latest news and ratings for Statera BioPharma and its competitors with MarketBeat's FREE daily newsletter.

About Statera BioPharma

Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule immunotherapies. Its product applies to autoimmune, inflammatory, infectious diseases and cancers. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Fort Collins, CO.

Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference
October 6, 2021 | finance.yahoo.com

Statera Biopharma Announces CEO Mike Handley to Speak During Virtual B & T Cell-Mediated Autoimmune Disease Drug Development Summit
October 5, 2021 | finance.yahoo.com

Statera BioPharma, Inc. Provides Update on Integration of ImQuest
October 4, 2021 | finance.yahoo.com

Statera BioPharma, Inc. to Ring Nasdaq Stock Market Closing Bell
October 4, 2021 | finance.yahoo.com

Statera Biopharma, Inc. to Participate in the Cantor Virtual Global Healthcare Conference
October 4, 2021 | finance.yahoo.com

Statera Biopharma, Inc. to Participate in the Benzinga Healthcare Small Cap Conference
October 4, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:STAB
Previous Symbol
CUSIP: N/A
CIK: 1318641
Web: www.staterabiopharma.com
Phone: (888) 613-8802
Employees: 4
Year Founded: N/A

Sales & Book Value

Annual Sales: $260,000.00
Price / Sales: 317.67
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.15 per share
Price / Book: 21.47

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: $-2.40 million
Net Margins: N/A
Return on Equity: -32.84%
Return on Assets: -31.29%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 45.93
Quick Ratio: 45.93

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 25,650,000
Market Cap: $82.59 million
Next Earnings Date: 11/15/2021 (Estimated)
Optionable: Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1352nd out of 1,361 stocks

Pharmaceutical Preparations Industry

665th out of 668 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Statera BioPharma.

0.0 Community Rank

Outperform Votes
Statera BioPharma has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Statera BioPharma has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Statera BioPharma and other stocks. Vote “Outperform” if you believe STAB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe STAB will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Statera BioPharma does not currently pay a dividend.
Dividend Growth
Statera BioPharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Statera BioPharma insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.03% of the stock of Statera BioPharma is held by insiders.
Percentage Held by Institutions
Only 5.09% of the stock of Statera BioPharma is held by institutions.

0.0 Earnings and Valuation

Price to Book Value per Share Ratio
Statera BioPharma has a P/B Ratio of 21.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Statera BioPharma (NASDAQ:STAB) Frequently Asked Questions

What stocks does MarketBeat like better than Statera BioPharma?: Wall Street analysts have given Statera BioPharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Statera BioPharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
When is Statera BioPharma's next earnings date?: Statera BioPharma is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.
View our earnings forecast for Statera BioPharma.
Who are Statera BioPharma's key executives?: Statera BioPharma's management team includes the following people:
Michael Kevin Handley, President, Chief Executive Officer & Director
Taunia S. Markvicka, Chief Operating Officer & Director
Peter J. Aronstam, Chief Financial Officer
Andrei V. Gudkov, Global Head-Research & Development
Clifford A. Selsky, Chief Medical Officer
Who are some of Statera BioPharma's key competitors?: Some companies that are related to Statera BioPharma include 9 Meters Biopharma (NMTR), ESSA Pharma (EPIX), MEI Pharma (MEIP), Spectrum Pharmaceuticals (SPPI), Vera Therapeutics (VERA), Fortress Biotech (FBIO), Nature's Sunshine Products (NATR), Neoleukin Therapeutics (NLTX), TherapeuticsMD (TXMD), Antibe Therapeutics (ATBPD), Citius Pharmaceuticals (CTXR), Verona Pharma (VRNA), Athenex (ATNX), Pieris Pharmaceuticals (PIRS) and Taiwan Liposome (TLC).
View all of STAB's competitors.
What is Statera BioPharma's stock symbol?: Statera BioPharma trades on the NASDAQ under the ticker symbol "STAB."
How do I buy shares of Statera BioPharma?: Shares of STAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Statera BioPharma's stock price today?: One share of STAB stock can currently be purchased for approximately $3.22.
How much money does Statera BioPharma make?: Statera BioPharma has a market capitalization of $82.59 million and generates $260,000.00 in revenue each year.
How many employees does Statera BioPharma have?: Statera BioPharma employs 4 workers across the globe.
What is Statera BioPharma's official website?: The official website for Statera BioPharma is www.staterabiopharma.com.
How can I contact Statera BioPharma?: The company can be reached via phone at (888) 613-8802.

This page was last updated on 10/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Statera BioPharma Stock Forecast, Price & News

About Statera BioPharma

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Insiders

Percentage Held by Institutions

0.0 Earnings and Valuation

Price to Book Value per Share Ratio

Statera BioPharma (NASDAQ:STAB) Frequently Asked Questions

What stocks does MarketBeat like better than Statera BioPharma?

When is Statera BioPharma's next earnings date?

Who are Statera BioPharma's key executives?

Who are some of Statera BioPharma's key competitors?

What is Statera BioPharma's stock symbol?

How do I buy shares of Statera BioPharma?

What is Statera BioPharma's stock price today?

How much money does Statera BioPharma make?

How many employees does Statera BioPharma have?

What is Statera BioPharma's official website?

How can I contact Statera BioPharma?